Target intelligence / Profile preview

Teneurin transmembrane protein 3 (TENM3)

Target
TENM3
Molecular classification
Type II transmembrane glycoprotein, Cell adhesion molecule, Teneurin protein family, Receptor (homophilic adhesion receptor)
01

Overview

Teneurin transmembrane protein 3 (TENM3) is a large, evolutionarily conserved type II transmembrane glycoprotein and a member of the teneurin family, expressed in both vertebrates and invertebrates. TENM3 is prominently involved in the regulation of neural circuit formation, including axon pathfinding, synaptic organization in the motor and visual systems, and dendrite guidance. It acts largely as a homophilic cell adhesion molecule, facilitating connectivity and topographic mapping between neural structures, particularly in the thalamostriatal and retinogeniculate pathways. Mutations in TENM3 are linked to severe developmental disorders, most notably microphthalmia, coloboma, and developmental dysplasia of the hip; such mutations may disrupt neuronal projections, visual pathway innervation, and cartilage/bone development. The human TENM3 gene is expressed predominantly in neural and ocular tissues, and loss-of-function variants lead to severe ocular malformations, with some evidence pointing to broader neurodevelopmental or skeletal consequences. No approved drugs are currently known to target TENM3, and its critical developmental roles would pose safety concerns for any direct therapeutic modulation.

Other names
Teneurin-3Ten-m3ODZ3TNM3Ten-3Tenascin-M3KIAA1455ODZ3-like proteinprotein Odd Oz/ten-m homolog 3MCOPCB9MCOPS15TEN3testicular tissue protein Li 195
02

Biological functions

Regulation of neuronal developmentAxon guidanceSynaptic organizationDendrite guidanceVisual pathway developmentMotor skill acquisitionChondrogenesis (cartilage development)Cell adhesion
03

Disease associations

Eye malformations (microphthalmia, anophthalmia, coloboma)Visual pathway disordersDevelopmental dysplasia of the hip(Limited evidence: intellectual disability, cocaine dependence)
04

Safety considerations

Essential developmental functions suggest potential risk for developmental toxicity if targetedPossible impact on neuronal and skeletal development

Beyond the preview

Go deeper on Teneurin transmembrane protein 3 (TENM3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Teneurin transmembrane protein 3 (TENM3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call